88918-72-3

Usage

Sulfonamide derivative

A compound containing a sulfonamide functional group

Nitro group attached to benzene ring

A nitro group (-NO2) is attached to a benzene ring in the molecule

Intermediate/reagent

Used in the synthesis of various pharmaceuticals and organic compounds

Studied for biological/pharmacological activities

Including antibacterial and antifungal properties

Skin and eye irritant

Should be handled with caution in laboratory and industrial settings

Upstream product

• 53992-33-9 (4-nitrophenyl)-methanesulfonic acid 
• 4563-33-1 phenyl-methanesulfonic acid amide 
• 100-44-7 benzyl chloride 
• 100-87-8 Benzylsulfonic acid 
• 36639-50-6 Sodium 4-nitrobenzylsulphonate 
• 4025-75-6 (4-nitrophenyl)methanesulfonyl chloride 

Downstream Products

• 91647-24-4 3-(4-Nitro-benzylsulfonyl)-1-butyl-harnstoff 
• 110654-58-5 1,3,5-Tris-(4-nitro-phenylmethanesulfonyl)-[1,3,5]triazinane 
• 62-23-7 4-nitro-benzoic acid 
• 165669-09-0 4-(sulfamoylmethyl)benzenesulfonyl chloride 
• 4403-84-3 4-Aminobenzenemethanesulphonamide 

Relevant academic research and scientific papers

STRAD-BINDING AGENTS AND USES THEREOF

Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

Compounds and compositions useful for treating disorders related to KIT and PDFGR are described herein.

INHIBITORS OF PROTEIN KINASES

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).

Inhibitors of protein kinases

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceutical compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.

INHIBITORS OF PROTEIN KINASES

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).

Non-nucleoside reverse transcriptase inhibitors

The present invention provides for compounds useful for treating an HIV-1 infection, or preventing an HIV-1 infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R1-R4 and Ar are as herein defined. Also disclosed in t

NEW PYRIDINE ANALOGUES

The present invention relates to certain new pyridin analogues of Formula (I) Chemical formula should be inserted here. Please see paper copy Formula (I) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.